Tacrolimus targeted plain dose
Sponsors
University Hospital, Tours
Conditions
De Novo Transplant Disease
Phase 4
Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)
NCT01744470
Start: 2012-05-31End: 2015-03-31Updated: 2014-04-08
Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)
NCT02154854
Start: 2013-07-31End: 2015-03-31Target: 104Updated: 2014-06-03